Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 13, 2025

Von Willebrand Factor as a Therapeutic Target in Thrombotic Disorders.

View Full Paper
Ask AI
Bookmark
Share

Authors

YJYvonne K. JongejanLeiden University Medical CenterBVBart J.M. van VlijmenLeiden University Medical CenterJEJeroen EikenboomLeiden University Medical Center

Discussion

Loading...

Member takes

Overview

This review demonstrates the role of von willebrand factor in thrombosis, highlighting novel therapeutic agents and their implications.

Key Points

  • MAIN FINDING: Targeting von willebrand factor presents a promising therapeutic strategy in managing thrombotic disorders.
  • KEY EVIDENCE: Elevated plasma von willebrand factor levels can increase arterial thrombotic risk, while dysregulated levels relate to bleeding.
  • APPROACH: The review discusses the evolution of various therapeutic agents aimed at inhibitory effects on von willebrand factor.
  • SIGNIFICANCE: Understanding these agents may lead to safer and more effective treatments for patients at risk of thrombotic events.

Cite This Study

Jongejan et al. (2025) studied this question.

synapsesocial.com/papers/689e03efd61984b91e13d4e0https://doi.org/10.1055/a-2665-2313
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The function of ultra-large von Willebrand factor multimers in high shear flow controlled by ADAMTS132015 · 29 citations
  2. 2The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients2021 · 36 citations
  3. 3Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases2009 · 120 citations
  4. 4Pharmacokinetics and Pharmacodynamics of AJW200, a Humanized Monoclonal Antibody to von Willebrand Factor, in Monkeys2002 · 87 citations
  5. 5The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention2011 · 20 citations